Pharmacological potential of acetazolamide in traumatic intracranial hypertension  

作　　者：López-Cepeda Daniela Ramos-Villegas Yancarlos Padilla-Zambrano Huber S. Andrade-López Andrea Quintana-Pájaro Loraine Corrales-Santander Hugo Samer S.Hoz Luis Rafael Moscote-Salazar 无 

机构地区：[1]University of Cartagena,Cartagena de Indias,Bolivar,Colombia [2]Center for Biomedical Research,Faculty of Medicine-University of Cartagena,Cartagena Colombia [3]Cartagena Neurotrauma Research Group,Universidad de Cartagena,Colombia [4]Coordinator Center for Biomedical Research(CIB),Faculty of Medicine-University of Cartagena,Cartagena Colombia [5]Medicine Program-Rafael Nú?ez University Corporation,Cartagena,Colombia [6]Specialist in Neurosurgery,Faculty of Medicine-University of Cartagena,Cartagena de Indias,Bolívar,Colombia [7]Department of Neurosurgery,Neurosurgery teaching Hospital-Baghdad,Iraq

出　　处：《Journal of Acute Disease》2018年第4期149-151,共3页急性病杂志（英文版）

摘　　要：Traumatic brain injuries are an important cause of morbidity and mortality around the world. These types of lesions are often associated with increased intracranial pressure and cerebral edema, proper management of this can reduce tissue damage of the brain and improve brain perfusion. The use of acetazolamide is not indicated in guidelines for the management of intracranial hypertension, which is used to a great extent for the management of idiopathic intracranial hypertension. However, it is not yet known in the management of traumatic intracranial hypertension.

关 键 词：Brain injuries Intracranial hypertension ACETAZOLAMIDE 

分 类 号：R5[医药卫生—内科学]